
Pharmacally
Sarclisa
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Sarclisa
New Drug ApprovalEU Approves Sarclisa On-Body Injector Option for Multiple MyelomaThe European Commission has approved subcutaneous Sarclisa (isatuximab) across all existing EU indications for multiple myeloma, making it the first anticancer therapy available through an on-body injector in…Fact-Checked
Health TidingsSanofi’s Sarclisa SC Gets CHMP Nod with OBI OptionCHMP recommends approval of Sarclisa SC for multiple myeloma, supported by Phase 3 IRAKLIA data showing non-inferiority to IV formulation and improved patient experience…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.